Saby George

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Investigational new drugs

The oncologist

Roswell Park Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Roswell Park Cancer Institute Aug 16 2010

United States

GU Medical Oncologist :: Medicine

Publications

Daniel P Petrylak, Scott T Tagawa, Rohit K Jain, Manojkumar Bupathi, Arjun V Balar, Arash Rezazadeh Kalebasty, Saby George, Phillip Palmbos, Luke Nordquist, Nancy B Davis, Chethan Ramamurthy, Cora N Sternberg, Yohann Loriot, Archana M Agarwal, Chandler Park, Julia Tonelli, Morganna Vance, Huafeng Zhou, Petros D Grivas
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Peter H O'Donnell, Matthew I Milowsky, Daniel P Petrylak, Christopher J Hoimes, Thomas W Flaig, Nataliya Mar, Helen H Moon, Terence W Friedlander, Rana R McKay, Mehmet Asim Bilen, Sandy Srinivas, Earle F Burgess, Chethan Ramamurthy, Saby George, Daniel M Geynisman, Sergio Bracarda, Delphine Borchiellini, Lionnel Geoffrois, Jose Pablo Maroto Rey, Christiano Ferrario, Anne-Sophie Carret, Yao Yu, Maria Guseva, Blanca Homet Moreno, Jonathan E Rosenberg
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Daniel P Petrylak, Bernhard J Eigl, Saby George, Elisabeth I Heath, Sebastien J Hotte, David D Chism, Lisle M Nabell, Joel Picus, Susanna Y Cheng, Leonard J Appleman, Guru P Sonpavde, Alicia K Morgans, Pourya Pourhosseini, Ruishan Wu, Laura Standley, Ruslan Croitoru, Evan Y Yu
Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients With Metastatic Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Saby George, Elizabeth J Bell, Ying Zheng, Ruth Kim, John White, Geeta Devgan, Jodi Smith, Lincy S Lal, Nicole M Engel-Nitz, Frank X Liu
The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors. The oncologist 26 (7) (2021)
Nizar M Tannir, Sabina Signoretti, Toni K Choueiri, David F McDermott, Robert J Motzer, Abdallah Flaifel, Jean-Christophe Pignon, Miriam Ficial, Osvaldo Arén Frontera, Saby George, Thomas Powles, Frede Donskov, Michael R Harrison, Philippe Barthélémy, Scott S Tykodi, Judit Kocsis, Alain Ravaud, Jeronimo R Rodriguez-Cid, Sumanta K Pal, Andre M Murad, Yuko Ishii, Shruti Shally Saggi, M Brent McHenry, Brian I Rini
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (1) (2020)
Jean-Francois Martini, Elizabeth R Plimack, Toni K Choueiri, David F McDermott, Igor Puzanov, Mayer N Fishman, Daniel C Cho, Ulka Vaishampayan, Bradley Rosbrook, Kathrine C Fernandez, Jamal C Tarazi, Saby George, Michael B Atkins
Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (21) (2020)
Bradley Alexander McGregor, Michael S Gordon, Ronan Flippot, Archana M Agarwal, Saby George, David I Quinn, Mark Rogalski, Thomas Hawthorne, Tibor Keler, Toni K Choueiri
Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma. Investigational new drugs 38 (6) (2020)

Saby George.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Saby George